Home » Tenders » Asia » Japan » Test Reagent Tender, Japan - 103886500

Test Reagent Tender, Japan - 103886500

NATIONAL CANCER CENTER RESEARCH INSTITUTE has floated a tender for Test Reagent. The project location is Japan and the tender is closing on 29 Aug 2024. The tender notice number is , while the TOT Ref Number is 103886500. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Japan

Summary : Test Reagent

Deadline : 29 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 103886500

Document Ref. No. :

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :xxxxxxxxx

Address : xxxxxxxxx

Email : xxxxxxxxx

Tender Details

Test reagent
Classification :
0004 Medical & Pharmaceutical Products
Summay of Notice :
⑴ Official in charge of disbursement of the procuring entity : Hitoshi Nakagama, President of National Cancer Center
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased : Test reagent
⑷ Delivery period : From October 1, 2024 to September 30, 2025
⑸ Delivery place : National Cancer Center (Tsukiji, Kashiwa)
⑹ Qualification for participating in the tendering procedures : Supplierseligible for participating in the proposed tender are those who shall :
① not come under Article 6 of the Regulation concerning Contract for National Cancer Center. Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;
② not come under Article 7 of the Regulation concerning Contract for National Cancer Center ;
③ have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Kanto-Koshinetsu Regi-on ;
④ prove to have obtained the first-classlicense for selling drugs in accordance with the Pharmaceutical Affairs Law ;
⑤ prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;
...